An experimental pill developed by Merck & Co is being hailed as a potential breakthrough in Covid-19 treatment after data showed it could halve the chances of dying or being hospitalized in patients.
An experimental antiviral pill developed by Merck & Co could halve the chances of dying or being hospitalized for those most at risk of contracting severe C
Merck pill seen as a huge advance , raises hope of preventing COVID-19 deaths devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Oct 2 An experimental antiviral pill developed by Merck & Co could halve the chances of dying or being hospitalised for those most at risk of contracting severe Covid-19, according to data that experts hailed as a potential breakthrough in how the virus is treated. If it gets.